Irina A. Chikova

Saint Petersburg, SPE 194100, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Ethnic Differences in Juvenile Idiopathic Arthritis in the Circumpolar Region.

Ethnic Differences in Juvenile Idiopathic Arthritis in the Circumpolar Region.

Journal: Children (Basel, Switzerland)

Published: September 17, 2025

Features of patients with uveitis associated with juvenile idiopathic arthritis required eye surgery.

Features of patients with uveitis associated with juvenile idiopathic arthritis required eye surgery.

Journal: World journal of clinical pediatrics

Published: March 25, 2025

Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study.

Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study.

Journal: World journal of nephrology

Published: June 25, 2024

Initial Respiratory System Involvement in Juvenile Idiopathic Arthritis with Systemic Onset Is a Marker of Interstitial Lung Disease: The Results of Retrospective Cohort Study Analysis.

Initial Respiratory System Involvement in Juvenile Idiopathic Arthritis with Systemic Onset Is a Marker of Interstitial Lung Disease: The Results of Retrospective Cohort Study Analysis.

Journal: Journal of clinical medicine

Published: May 28, 2024

Clinical and laboratory features of juvenile idiopathic arthritis with wrist involvement: Results of a retrospective cohort study.

Clinical and laboratory features of juvenile idiopathic arthritis with wrist involvement: Results of a retrospective cohort study.

Journal: World journal of clinical pediatrics

Published: January 01, 2024

BCD020 rituximab bioanalog compared to standard treatment in juvenile systemic lupus erythematosus: The data of 12 months case-control study.

BCD020 rituximab bioanalog compared to standard treatment in juvenile systemic lupus erythematosus: The data of 12 months case-control study.

Journal: World journal of clinical pediatrics

Published: October 19, 2023

Case report: Sulfasalazine-induced hypersensitivity.

Case report: Sulfasalazine-induced hypersensitivity.

Journal: Frontiers in medicine

Published: January 08, 2023

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.

Journal: Frontiers in pediatrics

Published: March 12, 2022

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics.

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics.

Journal: Frontiers in pediatrics

Published: January 06, 2022

Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis.

Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis.

Journal: Rheumatology (Oxford, England)

Published: December 31, 2019

Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis.

Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis.

Journal: Rheumatology international

Published: July 16, 2018

Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.

Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.

Journal: Clinical and experimental rheumatology

Published: April 01, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026